Advanced company searchLink opens in new window

MESTAG THERAPEUTICS LTD

Company number 12466144

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
03 Jun 2025 AP01 Appointment of Martinus Adrianus Van Osch as a director on 2 June 2025
03 Jun 2025 TM01 Termination of appointment of Antoine Boulanger Piette as a director on 2 June 2025
22 May 2025 SH08 Change of share class name or designation
22 May 2025 SH06 Cancellation of shares. Statement of capital on 2 May 2025
  • GBP 4,725.1160
22 May 2025 SH03 Purchase of own shares.
08 May 2025 AA Accounts for a small company made up to 31 December 2024
29 Apr 2025 SH01 Statement of capital following an allotment of shares on 28 April 2025
  • GBP 4,758.716
24 Feb 2025 CS01 Confirmation statement made on 15 February 2025 with updates
09 Jan 2025 SH01 Statement of capital following an allotment of shares on 6 January 2025
  • GBP 4,757.2158
02 Jan 2025 SH01 Statement of capital following an allotment of shares on 23 December 2024
  • GBP 4,756.42
23 Oct 2024 PSC02 Notification of Johnson & Johnson as a person with significant control on 14 October 2024
23 Oct 2024 PSC09 Withdrawal of a person with significant control statement on 23 October 2024
23 Oct 2024 AA Accounts for a small company made up to 31 December 2023
17 Oct 2024 SH01 Statement of capital following an allotment of shares on 14 October 2024
  • GBP 4,563.5468
22 Jun 2024 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
19 Jun 2024 SH01 Statement of capital following an allotment of shares on 12 June 2024
  • GBP 4,563.5468
11 Mar 2024 TM01 Termination of appointment of Juliette Audet as a director on 29 February 2024
11 Mar 2024 AP01 Appointment of Dr Antoine Boulanger Piette as a director on 29 February 2024
21 Feb 2024 CS01 Confirmation statement made on 15 February 2024 with updates
18 Dec 2023 SH01 Statement of capital following an allotment of shares on 31 July 2023
  • GBP 4,330.4722
29 Nov 2023 SH01 Statement of capital following an allotment of shares on 22 November 2023
  • GBP 4,330.4722
11 Aug 2023 RP04SH01 Second filing of a statement of capital following an allotment of shares on 7 July 2023
  • GBP 4,330.4723
20 Jul 2023 SH01 Statement of capital following an allotment of shares on 7 July 2023
  • GBP 4,331
  • ANNOTATION Clarification a second filed SH01 was registered on 11/08/2023.
06 Jul 2023 AP01 Appointment of Mr Charles Dunn as a director on 29 June 2023
06 Jul 2023 TM01 Termination of appointment of Houman Ashrafian as a director on 29 June 2023